ArticleScientific reports2020

Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy.

Jeewon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.